Skip to content

FDA Releases Draft Agreement on PDUFA V

September 2, 2011

The U.S. Food & Drug Administration (FDA) has released a draft of performance goals and procedures agreed between industry and the agency that would underpin the Prescription Drug User Fee Act (PDUFA) V. The Biotechnology Industry Organization (BIO) has already made it clear that it is supportive of this draft set of recommendations.

Comments are closed.